PRICE T ROWE ASSOCIATES INC /MD/ - JOUNCE THERAPEUTICS INC ownership

JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 126 filers reported holding JOUNCE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.9%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of JOUNCE THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$149
+67.4%
80,3360.0%0.00%
Q4 2022$89
-99.9%
80,336
+104.2%
0.00%
Q3 2022$93,000
+57.6%
39,336
+100.5%
0.00%
Q2 2022$59,000
-86.5%
19,618
-69.5%
0.00%
Q1 2022$437,000
+414.1%
64,309
+530.9%
0.00%
Q4 2021$85,000
-94.3%
10,194
-94.9%
0.00%
Q3 2021$1,497,000
+18.4%
201,494
+8.4%
0.00%
Q2 2021$1,264,000
-12.5%
185,858
+32.2%
0.00%
Q1 2021$1,444,000
+96.5%
140,626
+33.9%
0.00%
Q4 2020$735,000104,9960.00%
Other shareholders
JOUNCE THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
TRV GP II, LLC 2,697,829$20,045,00088.84%
TRV GP III, LLC 3,048,780$22,652,0004.30%
Logos Global Management LP 2,000,000$14,860,0001.07%
SILVERARC CAPITAL MANAGEMENT, LLC 208,559$1,550,0000.88%
PFM Health Sciences, LP 3,848,822$28,597,0000.84%
Yorktown Management & Research Co Inc 113,200$841,0000.63%
Moloney Securities Asset Management, LLC 282,250$2,097,0000.38%
PATHWAY CAPITAL MANAGEMENT, LP 84,763$630,0000.30%
Sofinnova Investments, Inc. 637,347$4,735,0000.28%
Omega Fund Management, LLC 275,513$2,047,0000.23%
View complete list of JOUNCE THERAPEUTICS INC shareholders